Japan’s GHIT Fund Supports Dartmouth Researchers’ Second Tuberculosis Vaccine Trial

A collaborative of Dartmouth’s Geisel School of Medicine, Muhimbili University of Health and Allied Sciences in Tanzania, and Tokyo Medical and Dental University received $1.4 million from Japan’s Global Health Innovative Technology Fund to conduct a joint randomized clinical trial in Tanzania aimed at reducing the transmission of tuberculosis.
Source: News at Dartmouth Medical School - Category: Hospital Management Authors: Tags: News DarDar Features Ford Von Reyn TB tuberculosis vaccine Source Type: news